2 results
DDAVP treatment combined with FVIII clotting factor concentrates in patients with mild hemophilia A.
Primary objectives:To assess the proportion of non-severe hemophilia A patients within FVIII target levels with the DDAVP and FVIII concentrate combination treatment in the first 72 hours after the start of combination treatment, without adding off-…
Approved WMOPending
Main:The main objective is to explore the potential utility of MRCP+ and LMS in monitoring disease activity and early detection of worsening disease requiring endoscopic intervention. Secondary Objective(s): Assessment of mean, median, range and…